Why the study?
Polycystic ovary syndrome is a prevalent endocrine disorder in women of reproductive age, but its underlying molecular mechanisms remain unclear.
Does knockdown of lncRNA NONHSAT233728.1 promote granulosa cell apoptosis and mitochondrial dysfunction in PCOS models?
Does knockdown of lncRNA NONHSAT233728.1 promote granulosa cell apoptosis and mitochondrial dysfunction in PCOS models?
LncRNA NONHSAT233728.1 is downregulated in PCOS, and its knockdown promotes granulosa cell apoptosis via ROS accumulation and the MEK/ERK1/2 pathway, offering new mechanistic insights into follicular atresia.
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorders in women of reproductive age. However, the underlying molecular mechanism remains unclear. In this study, we employed RNA sequencing analysis to identify differentially expressed protein-coding genes and long noncoding RNA (lncRNA) expression profiles in granulosa cells from women with and without PCOS. It was established that the level of NONHSAT233728.1 was diminished in women with PCOS. The present study demonstrated the role of NONHSAT233728.1 in granulosa cells from patients with PCOS and further investigated the potential mechanism of NONHSAT233728.1 in the KGN cell line. Additionally, the knockdown of NONHSAT233728.1 has been observed to promote cell apoptosis, inhibit cell proliferation, promote mitochondrial dysfunction, and inflammation. Western blot analyses confirmed that phospho-extracellular regulated protein kinases (ERK)1/2 were decreased following lnc-NONHSAT233728.1 knockdown. Consequently, we propose that ROS accumulation activates the endogenous mitochondrial apoptosis pathway, leading to granulosa cell apoptosis via the MEK/ERK1/2 pathway, which contributes to follicular atresia. We observed a negative correlation between NONHSAT233728.1 and both LH levels and the LH/FSH ratio. These findings indicate that lncRNA NONHSAT233728.1 is linked to the pathogenesis of PCOS and offer new insights into its underlying mechanisms.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: